Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin

被引:28
|
作者
Gibson, JL
Ekevall, K
Walker, I
Greer, IA
机构
[1] Univ Glasgow, Glasgow Royal Infirm, Dept Obstet & Gynaecol, Glasgow G31 2ER, Lanark, Scotland
[2] Glasgow Royal Matern Hosp, Glasgow, Lanark, Scotland
来源
关键词
D O I
10.1111/j.1471-0528.1998.tb10212.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Low molecular weight heparins are used extensively for thromboprophylaxis. The aim of this study was to compare the activity of the low molecular weight heparin, enoxaparin, 20 mg and 40 mg, given once per day with unfractionated heparin, 7500iu given twice per day, in terms of their anti-Xa activity in puerperal women following caesarean section and with an additional risk factor for venous thromboembolism. Seventeen women were randomised to receive one of the three treatments. The anti-Xa activity associated with each treatment was measured prior to treatment and at 2, 4, 6, 12 and 24 hours. The mean anti-Xa values of the groups receiving enoxaparin, 20 mg and 40 mg, were significantly higher than those of the group receiving unfractionated heparin. There was no difference between the two enoxaparin groups in terms of the anti-Xa activity profiles. This study suggests that the use of enoxaparin is superior to unfractionated heparin in terms of anti-Xa activity.
引用
收藏
页码:795 / 797
页数:3
相关论文
共 50 条
  • [1] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
    Laifer, SA
    Casele, HL
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06): : 614 - 615
  • [2] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin - Reply
    Greer, IA
    Walker, ID
    Gibson, JE
    Ekevall, K
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06): : 615 - 615
  • [3] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    THROMBOSIS RESEARCH, 1997, 85 (03) : 259 - 265
  • [4] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (Enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1172 - P1172
  • [5] SUPRATHERAPEUTIC UNFRACTIONATED HEPARIN ANTI-XA LEVELS DUE TO TREATMENT-DOSE ENOXAPARIN EXPOSURE
    Anthes, Ananth
    Providence, Sarah
    Wilmer, Carrie
    Zhao, Xinhua
    Aspinall, Sherrie
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 467 - 467
  • [6] Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents
    Smahi, Motalib
    De Pooter, Neila
    Hollestelle, Martine J.
    Toulon, Pierre
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2613 - 2621
  • [7] COMPARISON OF ANTI-XA LEVELS BETWEEN OBESE AND NON-OBESE CRITICALLY ILL PATIENTS RECEIVING UNFRACTIONATED HEPARIN THROMBOPROPHYLAXIS
    Blum, Mark
    Park, Jayoung
    Wu, Wenchen
    Belchikov, Yuly
    Smith, Candace
    Barrera, Rafael
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U254 - U254
  • [8] Comparison of two intravenous unfractionated heparin dosing strategies: aPTT and anti-Xa monitoring
    Free, Nicole
    Szymanski, Becky
    Hipp, Tina
    Rozario, Nigel
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 611 - 611
  • [9] Comparison of Aptt and anti-Xa Activity with Patient Outcomes in a Large Cohort of Hospitalized Patients Treated with Unfractionated Heparin
    Jin, Jing
    Price, Elizabeth A.
    Houng Nguyen
    Krishnan, Gomathi
    Balise, Ray
    Bowen, Raffick
    Zehnder, James
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S174 - S174
  • [10] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin) (vol 85, pg 259, 1997)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    THROMBOSIS RESEARCH, 1997, 87 (02) : 269 - 269